“AI doesn’t have to be the first port of call. Many organisations still need to focus on the paper-to-glass journey before they can think about more advanced technologies”
Vishnu Dwadasi, Director of Life Sciences at West Monroe, brings extensive experience across pharmaceutical operations, consulting and business development from both the sponsor and CDMO sides. His career path through companies including Catalent, BioDuro, PII and now West Monroe has given him unique insights into the evolving pharmaceutical outsourcing landscape.
In the latest PharmaSource podcast episode, Vishnu shares his perspective on how private equity investments are reshaping the CDMO landscape, post-merger integration challenges, and the realistic pace of digital transformation within pharmaceutical manufacturing organisations.